Literature DB >> 11595284

New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.

R Kaul1, S L Rowland-Jones, J Kimani, K Fowke, T Dong, P Kiama, J Rutherford, E Njagi, F Mwangi, T Rostron, J Onyango, J Oyugi, K S MacDonald, J J Bwayo, F A Plummer.   

Abstract

A clearer understanding of HIV-1 specific immune responses in highly-exposed, persistently seronegative (HEPS) subjects is important in developing models of HIV-1 protective immunity. HIV-1 specific cytotoxic T-lymphocytes (CTL) have been described in a cohort of HEPS Kenyan sex workers, and recent work has further elucidated these responses. CTL specific for HIV-1 Env were found in the blood of over half the sex workers meeting criteria for HIV resistance, and in some women recognized unmapped epitopes. The proportion of women with Env-specific CTL increased with the duration of uninfected HIV exposure, suggesting that these responses were acquired over time. CD8+ lymphocyte responses directed against predefined HIV-1 CTL epitopes from various HIV-1 genes were found in the blood and genital tract of >50% resistant sex workers, at a ten-fold lower frequency than in infected subjects. The epitope specificity of CD8+ responses differs between HEPS and HIV infected women, and in HEPS the maintenance of responses appears to be dependent on persistent HIV exposure. Several HIV-1 'resistant' sex workers have become HIV infected over the past 6 years, possibly related to waning of pre-existing HIV-specific CTL, and infection has often been associated with a switch in the epitope specificity of CD8+ responses. These findings suggest that vaccine-induced protective HIV immunity is a realistic goal, but that vaccine strategies of boosting or persistent antigen may be necessary for long-lived protection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595284     DOI: 10.1016/s0165-2478(01)00260-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  39 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Resistance to HIV infection.

Authors:  M Marmor; K Hertzmark; S M Thomas; P N Halkitis; M Vogler
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 3.  Current advances and challenges in HIV-1 vaccines.

Authors:  Isaac R Rodriguez-Chavez; Mary Allen; Edgar L Hill; Rebecca L Sheets; Michael Pensiero; James A Bradac; M Patricia D'Souza
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

4.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

5.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

6.  Breast milk HIV-1 RNA levels and female sex are associated with HIV-1-specific CD8+ T-cell responses in HIV-1-exposed, uninfected infants in Kenya.

Authors:  Carey Farquhar; Barbara Lohman-Payne; Julie Overbaugh; Barbra A Richardson; Jennifer Mabuka; Rose Bosire; Dorothy Mbori-Ngacha; Grace John-Stewart
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

7.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa.

Authors:  Nico Nagelkerke; Sake J de Vlas; Prabhat Jha; Ma Luo; Francis A Plummer; Rupert Kaul
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

9.  Evaluation of a quantitative real-time PCR assay to measure HIV-specific mucosal CD8+ T cell responses in the cervix.

Authors:  Duncan Chege; Yijie Chai; Sanja Huibner; Lyle McKinnon; Charles Wachihi; Makubo Kimani; Walter Jaoko; Joshua Kimani; T Blake Ball; Francis A Plummer; Rupert Kaul; Anuradha Rebbapragada
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

10.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.